Trial · NCT01059448
Results by group300
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 300
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With a Treatment-emergent Adverse Event (TEAE) | Placebo Q2WK / 210 mg AMG 827 Q2WK | 28 | Participants | ||
| Number of Participants With a Treatment-emergent Adverse Event (TEAE) | 70 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 32 | Participants | ||
| Number of Participants With a Treatment-emergent Adverse Event (TEAE) | 140mg AMG 827 Q2WK / 210mg AMG 827 Q2WK | 31 | Participants | ||
| Number of Participants With a Treatment-emergent Adverse Event (TEAE) | 210 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 32 | Participants | ||
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | Placebo Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 2 | 21 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 70 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 2 | 24 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 140mg AMG 827 Q2WK / 210mg AMG 827 Q2WK | 20090402 Week 2 | 26 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 210 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 2 | 24 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | Placebo Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 4 | 27 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 70 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 4 | 26 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 140mg AMG 827 Q2WK / 210mg AMG 827 Q2WK | 20090402 Week 4 | 24 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 210 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 4 | 32 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | Placebo Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 8 | 27 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 70 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 8 | 31 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 140mg AMG 827 Q2WK / 210mg AMG 827 Q2WK | 20090402 Week 8 | 27 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 210 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 8 | 29 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | Placebo Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 12 | 25 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 70 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 12 | 24 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 140mg AMG 827 Q2WK / 210mg AMG 827 Q2WK | 20090402 Week 12 | 23 | Participants | |
| Number of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response | 210 mg AMG 827 Q2WK / 210 mg AMG 827 Q2WK | 20090402 Week 12 | 22 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01059448/results